Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease. // Cell Stem Cell. – URL: https://www.sciencedirect.com/science/article/pii/S1934590926003437?dgcid=rss_sd_all
Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease. Cell Stem Cell. https://www.sciencedirect.com/science/article/pii/S1934590926003437?dgcid=rss_sd_all
“Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease.” Cell Stem Cell.
@article{article2285,
title = {Systemic delivery of phagocytosis-shielded retroviral vectors enables in vivo HSC gene therapy for sickle cell disease},
journal = {Cell Stem Cell},
url = {https://www.sciencedirect.com/science/article/pii/S1934590926003437?dgcid=rss_sd_all}
}